nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—systemic lupus erythematosus	0.395	1	CbGaD
Clodronate—PTGS2—Dapsone—systemic lupus erythematosus	0.115	0.329	CbGbCtD
Clodronate—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0998	0.285	CbGbCtD
Clodronate—PTGS2—Betamethasone—systemic lupus erythematosus	0.0856	0.244	CbGbCtD
Clodronate—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0498	0.142	CbGbCtD
Clodronate—SLC25A6—Influenza Virus Induced Apoptosis—TGFB1—systemic lupus erythematosus	0.00819	0.149	CbGpPWpGaD
Clodronate—SLC25A6—connective tissue—systemic lupus erythematosus	0.00531	0.0551	CbGeAlD
Clodronate—SLC25A6—skin of body—systemic lupus erythematosus	0.0048	0.0498	CbGeAlD
Clodronate—SLC25A5—connective tissue—systemic lupus erythematosus	0.00462	0.048	CbGeAlD
Clodronate—SLC25A6—kidney—systemic lupus erythematosus	0.00452	0.0469	CbGeAlD
Clodronate—SLC25A5—nephron tubule—systemic lupus erythematosus	0.00448	0.0464	CbGeAlD
Clodronate—SLC25A5—skin of body—systemic lupus erythematosus	0.00417	0.0433	CbGeAlD
Clodronate—SLC25A6—Host Interactions with Influenza Factors—TGFB1—systemic lupus erythematosus	0.00394	0.0714	CbGpPWpGaD
Clodronate—SLC25A5—kidney—systemic lupus erythematosus	0.00393	0.0408	CbGeAlD
Clodronate—SLC25A6—lymphoid tissue—systemic lupus erythematosus	0.00388	0.0403	CbGeAlD
Clodronate—SLC25A5—cortex of kidney—systemic lupus erythematosus	0.00383	0.0398	CbGeAlD
Clodronate—SLC25A4—kidney—systemic lupus erythematosus	0.00369	0.0383	CbGeAlD
Clodronate—SLC25A4—cortex of kidney—systemic lupus erythematosus	0.00359	0.0373	CbGeAlD
Clodronate—SLC25A6—bone marrow—systemic lupus erythematosus	0.00354	0.0367	CbGeAlD
Clodronate—SLC25A5—lymphoid tissue—systemic lupus erythematosus	0.00338	0.0351	CbGeAlD
Clodronate—SLC25A6—lung—systemic lupus erythematosus	0.0032	0.0332	CbGeAlD
Clodronate—SLC25A5—tendon—systemic lupus erythematosus	0.00318	0.033	CbGeAlD
Clodronate—SLC25A5—bone marrow—systemic lupus erythematosus	0.00308	0.0319	CbGeAlD
Clodronate—SLC25A4—tendon—systemic lupus erythematosus	0.00298	0.0309	CbGeAlD
Clodronate—SLC25A6—nervous system—systemic lupus erythematosus	0.00297	0.0308	CbGeAlD
Clodronate—SLC25A6—central nervous system—systemic lupus erythematosus	0.00286	0.0296	CbGeAlD
Clodronate—SLC25A5—lung—systemic lupus erythematosus	0.00279	0.0289	CbGeAlD
Clodronate—SLC25A4—lung—systemic lupus erythematosus	0.00261	0.0271	CbGeAlD
Clodronate—SLC25A5—nervous system—systemic lupus erythematosus	0.00258	0.0268	CbGeAlD
Clodronate—SLC25A5—central nervous system—systemic lupus erythematosus	0.00249	0.0258	CbGeAlD
Clodronate—SLC25A4—nervous system—systemic lupus erythematosus	0.00242	0.0251	CbGeAlD
Clodronate—SLC25A4—central nervous system—systemic lupus erythematosus	0.00233	0.0242	CbGeAlD
Clodronate—PTGS2—endothelium—systemic lupus erythematosus	0.00184	0.0191	CbGeAlD
Clodronate—PTGS2—blood plasma—systemic lupus erythematosus	0.00163	0.017	CbGeAlD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00158	0.0287	CbGpPWpGaD
Clodronate—SLC25A5—Host Interactions of HIV factors—CD247—systemic lupus erythematosus	0.00148	0.0268	CbGpPWpGaD
Clodronate—SLC25A5—HIV Infection—XRCC6—systemic lupus erythematosus	0.00142	0.0258	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.00128	0.0233	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.00128	0.0233	CbGpPWpGaD
Clodronate—SLC25A6—Host Interactions of HIV factors—CD247—systemic lupus erythematosus	0.00124	0.0225	CbGpPWpGaD
Clodronate—SLC25A6—HIV Infection—XRCC6—systemic lupus erythematosus	0.00119	0.0216	CbGpPWpGaD
Clodronate—SLC25A4—Host Interactions of HIV factors—CD247—systemic lupus erythematosus	0.000968	0.0176	CbGpPWpGaD
Clodronate—SLC25A5—HIV Infection—CD247—systemic lupus erythematosus	0.000961	0.0174	CbGpPWpGaD
Clodronate—SLC25A4—HIV Infection—XRCC6—systemic lupus erythematosus	0.000931	0.0169	CbGpPWpGaD
Clodronate—Pharyngitis—Dapsone—systemic lupus erythematosus	0.000879	0.00888	CcSEcCtD
Clodronate—Hypercalcaemia—Methylprednisolone—systemic lupus erythematosus	0.000874	0.00882	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000873	0.0158	CbGpPWpGaD
Clodronate—PTGS2—connective tissue—systemic lupus erythematosus	0.00087	0.00903	CbGeAlD
Clodronate—Neoplasm malignant—Cyclosporine—systemic lupus erythematosus	0.000851	0.00859	CcSEcCtD
Clodronate—Hepatic function abnormal—Azathioprine—systemic lupus erythematosus	0.000828	0.00836	CcSEcCtD
Clodronate—SLC25A6—HIV Infection—CD247—systemic lupus erythematosus	0.000805	0.0146	CbGpPWpGaD
Clodronate—PTGS2—skin of body—systemic lupus erythematosus	0.000786	0.00815	CbGeAlD
Clodronate—Hypocalcaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000775	0.00782	CcSEcCtD
Clodronate—Oliguria—Mycophenolate mofetil—systemic lupus erythematosus	0.000769	0.00777	CcSEcCtD
Clodronate—Creatinine increased—Cyclosporine—systemic lupus erythematosus	0.000764	0.00771	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.00076	0.0138	CbGpPWpGaD
Clodronate—Creatinine increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000745	0.00752	CcSEcCtD
Clodronate—PTGS2—kidney—systemic lupus erythematosus	0.000741	0.00769	CbGeAlD
Clodronate—Hepatocellular injury—Cyclosporine—systemic lupus erythematosus	0.000727	0.00734	CcSEcCtD
Clodronate—Hepatocellular injury—Mycophenolate mofetil—systemic lupus erythematosus	0.000709	0.00716	CcSEcCtD
Clodronate—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000699	0.159	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000688	0.156	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000688	0.156	CbGdCrCtD
Clodronate—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000672	0.153	CbGdCrCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.000672	0.0122	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.00065	0.0118	CbGpPWpGaD
Clodronate—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000636	0.0066	CbGeAlD
Clodronate—Extravasation—Dexamethasone—systemic lupus erythematosus	0.000633	0.00639	CcSEcCtD
Clodronate—Extravasation—Betamethasone—systemic lupus erythematosus	0.000633	0.00639	CcSEcCtD
Clodronate—SLC25A4—HIV Infection—CD247—systemic lupus erythematosus	0.000629	0.0114	CbGpPWpGaD
Clodronate—Hepatic function abnormal—Cyclosporine—systemic lupus erythematosus	0.000604	0.0061	CcSEcCtD
Clodronate—PTGS2—tendon—systemic lupus erythematosus	0.000598	0.00621	CbGeAlD
Clodronate—Wheezing—Triamcinolone—systemic lupus erythematosus	0.000591	0.00596	CcSEcCtD
Clodronate—Liver disorder—Methotrexate—systemic lupus erythematosus	0.000589	0.00595	CcSEcCtD
Clodronate—PTGS2—bone marrow—systemic lupus erythematosus	0.000579	0.00601	CbGeAlD
Clodronate—Pneumonia—Azathioprine—systemic lupus erythematosus	0.000561	0.00567	CcSEcCtD
Clodronate—Renal failure acute—Mycophenolate mofetil—systemic lupus erythematosus	0.000558	0.00563	CcSEcCtD
Clodronate—Renal impairment—Cyclosporine—systemic lupus erythematosus	0.000554	0.0056	CcSEcCtD
Clodronate—Renal impairment—Mycophenolate mofetil—systemic lupus erythematosus	0.000541	0.00546	CcSEcCtD
Clodronate—Cardiac failure—Cyclosporine—systemic lupus erythematosus	0.000541	0.00546	CcSEcCtD
Clodronate—Pneumonia—Leflunomide—systemic lupus erythematosus	0.00053	0.00535	CcSEcCtD
Clodronate—Cardiac failure—Mycophenolate mofetil—systemic lupus erythematosus	0.000527	0.00533	CcSEcCtD
Clodronate—PTGS2—lung—systemic lupus erythematosus	0.000525	0.00545	CbGeAlD
Clodronate—Renal failure—Leflunomide—systemic lupus erythematosus	0.000518	0.00523	CcSEcCtD
Clodronate—SLC25A5—HIV Infection—CCR5—systemic lupus erythematosus	0.000512	0.00929	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000505	0.00916	CbGpPWpGaD
Clodronate—Abdominal pain—Dapsone—systemic lupus erythematosus	0.000497	0.00502	CcSEcCtD
Clodronate—SLC25A5—Host Interactions of HIV factors—CD4—systemic lupus erythematosus	0.000495	0.00898	CbGpPWpGaD
Clodronate—Blood creatinine increased—Cyclosporine—systemic lupus erythematosus	0.000494	0.00499	CcSEcCtD
Clodronate—PTGS2—nervous system—systemic lupus erythematosus	0.000486	0.00504	CbGeAlD
Clodronate—Blood creatinine increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000482	0.00487	CcSEcCtD
Clodronate—Abdominal pain upper—Cyclosporine—systemic lupus erythematosus	0.000482	0.00487	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.000481	0.00872	CbGpPWpGaD
Clodronate—Cardiac failure—Hydrocortisone—systemic lupus erythematosus	0.00048	0.00485	CcSEcCtD
Clodronate—Dehydration—Mycophenolate mofetil—systemic lupus erythematosus	0.000479	0.00483	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000473	0.00858	CbGpPWpGaD
Clodronate—Pharyngitis—Leflunomide—systemic lupus erythematosus	0.000469	0.00474	CcSEcCtD
Clodronate—PTGS2—central nervous system—systemic lupus erythematosus	0.000468	0.00486	CbGeAlD
Clodronate—Urinary tract disorder—Leflunomide—systemic lupus erythematosus	0.000467	0.00472	CcSEcCtD
Clodronate—Connective tissue disorder—Leflunomide—systemic lupus erythematosus	0.000465	0.00469	CcSEcCtD
Clodronate—Urethral disorder—Leflunomide—systemic lupus erythematosus	0.000464	0.00468	CcSEcCtD
Clodronate—Extravasation—Methotrexate—systemic lupus erythematosus	0.00046	0.00465	CcSEcCtD
Clodronate—Proteinuria—Methotrexate—systemic lupus erythematosus	0.000457	0.00462	CcSEcCtD
Clodronate—Dysphagia—Cyclosporine—systemic lupus erythematosus	0.000456	0.0046	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000454	0.00458	CcSEcCtD
Clodronate—Cardiac failure—Methylprednisolone—systemic lupus erythematosus	0.000451	0.00456	CcSEcCtD
Clodronate—Mediastinal disorder—Azathioprine—systemic lupus erythematosus	0.000451	0.00456	CcSEcCtD
Clodronate—Protein urine present—Methotrexate—systemic lupus erythematosus	0.000451	0.00455	CcSEcCtD
Clodronate—Bronchospasm—Cyclosporine—systemic lupus erythematosus	0.000449	0.00453	CcSEcCtD
Clodronate—Dysphagia—Mycophenolate mofetil—systemic lupus erythematosus	0.000445	0.00449	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.000445	0.00807	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000441	0.008	CbGpPWpGaD
Clodronate—Oliguria—Methotrexate—systemic lupus erythematosus	0.000436	0.0044	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000431	0.00781	CbGpPWpGaD
Clodronate—SLC25A6—HIV Infection—CCR5—systemic lupus erythematosus	0.000429	0.00779	CbGpPWpGaD
Clodronate—Abdominal pain upper—Hydrocortisone—systemic lupus erythematosus	0.000428	0.00432	CcSEcCtD
Clodronate—Mediastinal disorder—Leflunomide—systemic lupus erythematosus	0.000426	0.0043	CcSEcCtD
Clodronate—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000424	0.00769	CbGpPWpGaD
Clodronate—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000422	0.0958	CbGdCrCtD
Clodronate—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000415	0.0942	CbGdCrCtD
Clodronate—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000415	0.0942	CbGdCrCtD
Clodronate—SLC25A6—Host Interactions of HIV factors—CD4—systemic lupus erythematosus	0.000415	0.00752	CbGpPWpGaD
Clodronate—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.000414	0.00418	CcSEcCtD
Clodronate—Cardiac failure—Dexamethasone—systemic lupus erythematosus	0.000411	0.00414	CcSEcCtD
Clodronate—Cardiac failure—Betamethasone—systemic lupus erythematosus	0.000411	0.00414	CcSEcCtD
Clodronate—Pneumonia—Cyclosporine—systemic lupus erythematosus	0.000409	0.00413	CcSEcCtD
Clodronate—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000406	0.0921	CbGdCrCtD
Clodronate—Anaemia—Azathioprine—systemic lupus erythematosus	0.000403	0.00407	CcSEcCtD
Clodronate—Vomiting—Dapsone—systemic lupus erythematosus	0.0004	0.00404	CcSEcCtD
Clodronate—Renal failure—Cyclosporine—systemic lupus erythematosus	0.0004	0.00404	CcSEcCtD
Clodronate—Pneumonia—Mycophenolate mofetil—systemic lupus erythematosus	0.000399	0.00403	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000394	0.00715	CbGpPWpGaD
Clodronate—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.00039	0.00394	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.000389	0.00392	CcSEcCtD
Clodronate—Anaemia—Leflunomide—systemic lupus erythematosus	0.000381	0.00384	CcSEcCtD
Clodronate—Angioedema—Leflunomide—systemic lupus erythematosus	0.000376	0.0038	CcSEcCtD
Clodronate—Bronchospasm—Methylprednisolone—systemic lupus erythematosus	0.000375	0.00378	CcSEcCtD
Clodronate—Nausea—Dapsone—systemic lupus erythematosus	0.000374	0.00377	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000369	0.00372	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	0.000365	0.00662	CbGpPWpGaD
Clodronate—Pharyngitis—Cyclosporine—systemic lupus erythematosus	0.000362	0.00366	CcSEcCtD
Clodronate—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.00036	0.00364	CcSEcCtD
Clodronate—Connective tissue disorder—Cyclosporine—systemic lupus erythematosus	0.000359	0.00362	CcSEcCtD
Clodronate—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000358	0.00361	CcSEcCtD
Clodronate—Cardiac failure—Prednisone—systemic lupus erythematosus	0.000358	0.00361	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	0.000355	0.00644	CbGpPWpGaD
Clodronate—Infection—Azathioprine—systemic lupus erythematosus	0.000353	0.00357	CcSEcCtD
Clodronate—Pharyngitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000353	0.00357	CcSEcCtD
Clodronate—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000352	0.00355	CcSEcCtD
Clodronate—Connective tissue disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00035	0.00353	CcSEcCtD
Clodronate—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000349	0.00352	CcSEcCtD
Clodronate—SLC25A5—Disease—XRCC6—systemic lupus erythematosus	0.000349	0.00632	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000348	0.00351	CcSEcCtD
Clodronate—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000346	0.00349	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	0.000339	0.00616	CbGpPWpGaD
Clodronate—SLC25A4—HIV Infection—CCR5—systemic lupus erythematosus	0.000335	0.00608	CbGpPWpGaD
Clodronate—Infection—Leflunomide—systemic lupus erythematosus	0.000334	0.00337	CcSEcCtD
Clodronate—Mediastinal disorder—Cyclosporine—systemic lupus erythematosus	0.000329	0.00332	CcSEcCtD
Clodronate—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000326	0.0033	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	0.000325	0.0059	CbGpPWpGaD
Clodronate—SLC25A4—Host Interactions of HIV factors—CD4—systemic lupus erythematosus	0.000324	0.00587	CbGpPWpGaD
Clodronate—SLC25A5—HIV Infection—CD4—systemic lupus erythematosus	0.000322	0.00583	CbGpPWpGaD
Clodronate—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000321	0.00324	CcSEcCtD
Clodronate—Anorexia—Leflunomide—systemic lupus erythematosus	0.00032	0.00323	CcSEcCtD
Clodronate—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000319	0.00322	CcSEcCtD
Clodronate—Renal failure acute—Methotrexate—systemic lupus erythematosus	0.000316	0.00319	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000308	0.00311	CcSEcCtD
Clodronate—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000307	0.0031	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.000306	0.00555	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000304	0.00551	CbGpPWpGaD
Clodronate—Pharyngitis—Triamcinolone—systemic lupus erythematosus	0.000303	0.00306	CcSEcCtD
Clodronate—Dyspnoea—Leflunomide—systemic lupus erythematosus	0.0003	0.00302	CcSEcCtD
Clodronate—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000299	0.00302	CcSEcCtD
Clodronate—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000296	0.00299	CcSEcCtD
Clodronate—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000294	0.00297	CcSEcCtD
Clodronate—SLC25A6—Disease—XRCC6—systemic lupus erythematosus	0.000292	0.0053	CbGpPWpGaD
Clodronate—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000292	0.00295	CcSEcCtD
Clodronate—Angioedema—Cyclosporine—systemic lupus erythematosus	0.00029	0.00293	CcSEcCtD
Clodronate—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00029	0.00293	CcSEcCtD
Clodronate—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000286	0.00289	CcSEcCtD
Clodronate—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000283	0.00286	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000283	0.00513	CbGpPWpGaD
Clodronate—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000281	0.00284	CcSEcCtD
Clodronate—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.000275	0.00277	CcSEcCtD
Clodronate—SLC25A6—Influenza Infection—TGFB1—systemic lupus erythematosus	0.000272	0.00494	CbGpPWpGaD
Clodronate—SLC25A6—HIV Infection—CD4—systemic lupus erythematosus	0.00027	0.00489	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000269	0.00271	CcSEcCtD
Clodronate—Urticaria—Leflunomide—systemic lupus erythematosus	0.000267	0.0027	CcSEcCtD
Clodronate—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000266	0.00268	CcSEcCtD
Clodronate—Angioedema—Prednisolone—systemic lupus erythematosus	0.000264	0.00267	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.00265	CcSEcCtD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	0.000261	0.00473	CbGpPWpGaD
Clodronate—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000258	0.00261	CcSEcCtD
Clodronate—Infection—Cyclosporine—systemic lupus erythematosus	0.000258	0.0026	CcSEcCtD
Clodronate—SLC25A5—Disease—HIST2H2AC—systemic lupus erythematosus	0.000257	0.00466	CbGpPWpGaD
Clodronate—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000252	0.00254	CcSEcCtD
Clodronate—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000251	0.00254	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	0.000251	0.00455	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CSK—systemic lupus erythematosus	0.00025	0.00454	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—ACE—systemic lupus erythematosus	0.00025	0.00454	CbGpPWpGaD
Clodronate—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000247	0.0025	CcSEcCtD
Clodronate—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00248	CcSEcCtD
Clodronate—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000243	0.00246	CcSEcCtD
Clodronate—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000243	0.00245	CcSEcCtD
Clodronate—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000242	0.00245	CcSEcCtD
Clodronate—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000241	0.00243	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000239	0.00241	CcSEcCtD
Clodronate—Pruritus—Leflunomide—systemic lupus erythematosus	0.000238	0.0024	CcSEcCtD
Clodronate—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000237	0.00239	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000236	0.00428	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CD247—systemic lupus erythematosus	0.000235	0.00427	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NAT2—systemic lupus erythematosus	0.000235	0.00427	CbGpPWpGaD
Clodronate—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000231	0.00233	CcSEcCtD
Clodronate—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00023	0.00232	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	0.00023	0.00417	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NCF2—systemic lupus erythematosus	0.000229	0.00415	CbGpPWpGaD
Clodronate—Infection—Hydrocortisone—systemic lupus erythematosus	0.000229	0.00231	CcSEcCtD
Clodronate—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000228	0.0023	CcSEcCtD
Clodronate—SLC25A4—Disease—XRCC6—systemic lupus erythematosus	0.000228	0.00414	CbGpPWpGaD
Clodronate—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	0.000227	0.00413	CbGpPWpGaD
Clodronate—Vomiting—Azathioprine—systemic lupus erythematosus	0.000226	0.00228	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—systemic lupus erythematosus	0.000226	0.00228	CcSEcCtD
Clodronate—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000226	0.00228	CcSEcCtD
Clodronate—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000225	0.00228	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.000225	0.00409	CbGpPWpGaD
Clodronate—Rash—Azathioprine—systemic lupus erythematosus	0.000224	0.00227	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000224	0.00226	CcSEcCtD
Clodronate—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000224	0.00226	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000224	0.00226	CcSEcCtD
Clodronate—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000224	0.00226	CcSEcCtD
Clodronate—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000223	0.00225	CcSEcCtD
Clodronate—Renal failure—Methotrexate—systemic lupus erythematosus	0.000221	0.00223	CcSEcCtD
Clodronate—Angioedema—Betamethasone—systemic lupus erythematosus	0.00022	0.00223	CcSEcCtD
Clodronate—Angioedema—Dexamethasone—systemic lupus erythematosus	0.00022	0.00223	CcSEcCtD
Clodronate—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.00022	0.00222	CcSEcCtD
Clodronate—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.00022	0.00222	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	0.00022	0.00398	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000218	0.00221	CcSEcCtD
Clodronate—Infection—Triamcinolone—systemic lupus erythematosus	0.000216	0.00218	CcSEcCtD
Clodronate—SLC25A6—Disease—HIST2H2AC—systemic lupus erythematosus	0.000215	0.00391	CbGpPWpGaD
Clodronate—Infection—Methylprednisolone—systemic lupus erythematosus	0.000215	0.00217	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	0.000215	0.00389	CbGpPWpGaD
Clodronate—Vomiting—Leflunomide—systemic lupus erythematosus	0.000214	0.00216	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.000213	0.00387	CbGpPWpGaD
Clodronate—Rash—Leflunomide—systemic lupus erythematosus	0.000212	0.00214	CcSEcCtD
Clodronate—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000212	0.00214	CcSEcCtD
Clodronate—Nausea—Azathioprine—systemic lupus erythematosus	0.000211	0.00213	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	0.00021	0.00382	CbGpPWpGaD
Clodronate—SLC25A4—HIV Infection—CD4—systemic lupus erythematosus	0.00021	0.00382	CbGpPWpGaD
Clodronate—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.00021	0.00212	CcSEcCtD
Clodronate—SLC25A6—Disease—CSK—systemic lupus erythematosus	0.00021	0.00381	CbGpPWpGaD
Clodronate—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000206	0.00208	CcSEcCtD
Clodronate—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000205	0.00207	CcSEcCtD
Clodronate—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000203	0.00205	CcSEcCtD
Clodronate—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000201	0.00203	CcSEcCtD
Clodronate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.0002	0.00202	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.0002	0.00202	CcSEcCtD
Clodronate—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.00202	CcSEcCtD
Clodronate—Nausea—Leflunomide—systemic lupus erythematosus	0.0002	0.00202	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000199	0.00201	CcSEcCtD
Clodronate—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000199	0.00201	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000198	0.002	CcSEcCtD
Clodronate—SLC25A6—Disease—CD247—systemic lupus erythematosus	0.000197	0.00358	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NAT2—systemic lupus erythematosus	0.000197	0.00358	CbGpPWpGaD
Clodronate—Infection—Dexamethasone—systemic lupus erythematosus	0.000196	0.00198	CcSEcCtD
Clodronate—Infection—Betamethasone—systemic lupus erythematosus	0.000196	0.00198	CcSEcCtD
Clodronate—SLC25A4—Metabolism of proteins—ACE—systemic lupus erythematosus	0.000195	0.00354	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000195	0.00354	CbGpPWpGaD
Clodronate—Anaemia—Prednisone—systemic lupus erythematosus	0.000194	0.00196	CcSEcCtD
Clodronate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000193	0.00195	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	0.000192	0.00349	CbGpPWpGaD
Clodronate—Angioedema—Prednisone—systemic lupus erythematosus	0.000192	0.00194	CcSEcCtD
Clodronate—SLC25A6—Disease—NCF2—systemic lupus erythematosus	0.000192	0.00348	CbGpPWpGaD
Clodronate—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000191	0.00193	CcSEcCtD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	0.000191	0.00346	CbGpPWpGaD
Clodronate—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000191	0.00192	CcSEcCtD
Clodronate—Anorexia—Betamethasone—systemic lupus erythematosus	0.000188	0.0019	CcSEcCtD
Clodronate—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000188	0.0019	CcSEcCtD
Clodronate—Urticaria—Prednisolone—systemic lupus erythematosus	0.000187	0.00189	CcSEcCtD
Clodronate—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000183	0.00185	CcSEcCtD
Clodronate—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000183	0.00185	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000183	0.00332	CbGpPWpGaD
Clodronate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000182	0.00184	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000182	0.00184	CcSEcCtD
Clodronate—SLC25A5—Disease—JUNB—systemic lupus erythematosus	0.00018	0.00326	CbGpPWpGaD
Clodronate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000179	0.00181	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000178	0.00179	CcSEcCtD
Clodronate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000177	0.00179	CcSEcCtD
Clodronate—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000173	0.00175	CcSEcCtD
Clodronate—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000173	0.00175	CcSEcCtD
Clodronate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000173	0.00175	CcSEcCtD
Clodronate—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000172	0.00174	CcSEcCtD
Clodronate—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000172	0.00174	CcSEcCtD
Clodronate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000171	0.00173	CcSEcCtD
Clodronate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000171	0.00173	CcSEcCtD
Clodronate—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000171	0.00173	CcSEcCtD
Clodronate—Infection—Prednisone—systemic lupus erythematosus	0.00017	0.00172	CcSEcCtD
Clodronate—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00017	0.00172	CcSEcCtD
Clodronate—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00017	0.00172	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	0.000169	0.00307	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HIST2H2AC—systemic lupus erythematosus	0.000168	0.00305	CbGpPWpGaD
Clodronate—Skin disorder—Prednisone—systemic lupus erythematosus	0.000167	0.00168	CcSEcCtD
Clodronate—SLC25A5—Disease—PRL—systemic lupus erythematosus	0.000166	0.003	CbGpPWpGaD
Clodronate—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000165	0.00166	CcSEcCtD
Clodronate—SLC25A4—Disease—CSK—systemic lupus erythematosus	0.000164	0.00297	CbGpPWpGaD
Clodronate—Rash—Cyclosporine—systemic lupus erythematosus	0.000164	0.00165	CcSEcCtD
Clodronate—Anorexia—Prednisone—systemic lupus erythematosus	0.000163	0.00165	CcSEcCtD
Clodronate—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000163	0.00165	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	0.000163	0.00296	CbGpPWpGaD
Clodronate—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000163	0.00165	CcSEcCtD
Clodronate—Anaemia—Methotrexate—systemic lupus erythematosus	0.000162	0.00164	CcSEcCtD
Clodronate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00162	CcSEcCtD
Clodronate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.00161	CcSEcCtD
Clodronate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000159	0.00161	CcSEcCtD
Clodronate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000158	0.00159	CcSEcCtD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000157	0.00285	CbGpPWpGaD
Clodronate—Urticaria—Betamethasone—systemic lupus erythematosus	0.000156	0.00158	CcSEcCtD
Clodronate—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000156	0.00158	CcSEcCtD
Clodronate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000156	0.00157	CcSEcCtD
Clodronate—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000156	0.00157	CcSEcCtD
Clodronate—Nausea—Cyclosporine—systemic lupus erythematosus	0.000154	0.00156	CcSEcCtD
Clodronate—SLC25A4—Disease—CD247—systemic lupus erythematosus	0.000154	0.00279	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NAT2—systemic lupus erythematosus	0.000154	0.00279	CbGpPWpGaD
Clodronate—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000154	0.00155	CcSEcCtD
Clodronate—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000153	0.00155	CcSEcCtD
Clodronate—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000151	0.00152	CcSEcCtD
Clodronate—SLC25A6—Disease—JUNB—systemic lupus erythematosus	0.000151	0.00273	CbGpPWpGaD
Clodronate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.00152	CcSEcCtD
Clodronate—SLC25A4—Disease—NCF2—systemic lupus erythematosus	0.00015	0.00272	CbGpPWpGaD
Clodronate—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000149	0.00151	CcSEcCtD
Clodronate—Rash—Prednisolone—systemic lupus erythematosus	0.000149	0.0015	CcSEcCtD
Clodronate—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000149	0.0015	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000148	0.0015	CcSEcCtD
Clodronate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000148	0.0015	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000148	0.00268	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—F2—systemic lupus erythematosus	0.000147	0.00266	CbGpPWpGaD
Clodronate—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00148	CcSEcCtD
Clodronate—Rash—Hydrocortisone—systemic lupus erythematosus	0.000145	0.00147	CcSEcCtD
Clodronate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000145	0.00147	CcSEcCtD
Clodronate—Infection—Methotrexate—systemic lupus erythematosus	0.000142	0.00144	CcSEcCtD
Clodronate—Nausea—Prednisolone—systemic lupus erythematosus	0.00014	0.00142	CcSEcCtD
Clodronate—Pruritus—Betamethasone—systemic lupus erythematosus	0.000139	0.00141	CcSEcCtD
Clodronate—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000139	0.00141	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000139	0.00141	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	0.000139	0.00252	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PRL—systemic lupus erythematosus	0.000139	0.00252	CbGpPWpGaD
Clodronate—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000138	0.00139	CcSEcCtD
Clodronate—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00139	CcSEcCtD
Clodronate—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00138	CcSEcCtD
Clodronate—Rash—Triamcinolone—systemic lupus erythematosus	0.000137	0.00138	CcSEcCtD
Clodronate—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000137	0.00138	CcSEcCtD
Clodronate—Anorexia—Methotrexate—systemic lupus erythematosus	0.000137	0.00138	CcSEcCtD
Clodronate—Rash—Methylprednisolone—systemic lupus erythematosus	0.000137	0.00138	CcSEcCtD
Clodronate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000136	0.00138	CcSEcCtD
Clodronate—Urticaria—Prednisone—systemic lupus erythematosus	0.000136	0.00138	CcSEcCtD
Clodronate—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000136	0.00137	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	0.000135	0.00245	CbGpPWpGaD
Clodronate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000135	0.00136	CcSEcCtD
Clodronate—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000135	0.00136	CcSEcCtD
Clodronate—SLC25A5—Disease—JAK1—systemic lupus erythematosus	0.000132	0.0024	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—RXRA—systemic lupus erythematosus	0.000132	0.00239	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CCL2—systemic lupus erythematosus	0.000131	0.00237	CbGpPWpGaD
Clodronate—Nausea—Triamcinolone—systemic lupus erythematosus	0.000129	0.0013	CcSEcCtD
Clodronate—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000129	0.0013	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000128	0.00129	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000126	0.00229	CbGpPWpGaD
Clodronate—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000126	0.00127	CcSEcCtD
Clodronate—SLC25A5—Disease—CCR5—systemic lupus erythematosus	0.000125	0.00228	CbGpPWpGaD
Clodronate—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000125	0.00126	CcSEcCtD
Clodronate—Vomiting—Betamethasone—systemic lupus erythematosus	0.000125	0.00126	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000125	0.00126	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	0.000124	0.00226	CbGpPWpGaD
Clodronate—Rash—Betamethasone—systemic lupus erythematosus	0.000124	0.00125	CcSEcCtD
Clodronate—Rash—Dexamethasone—systemic lupus erythematosus	0.000124	0.00125	CcSEcCtD
Clodronate—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000124	0.00125	CcSEcCtD
Clodronate—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000124	0.00125	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000124	0.00125	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	0.000123	0.00224	CbGpPWpGaD
Clodronate—Pruritus—Prednisone—systemic lupus erythematosus	0.000121	0.00122	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	0.000118	0.00215	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JUNB—systemic lupus erythematosus	0.000118	0.00213	CbGpPWpGaD
Clodronate—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000117	0.00118	CcSEcCtD
Clodronate—Nausea—Dexamethasone—systemic lupus erythematosus	0.000117	0.00118	CcSEcCtD
Clodronate—Nausea—Betamethasone—systemic lupus erythematosus	0.000117	0.00118	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000117	0.00211	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	0.000116	0.0021	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—F2—systemic lupus erythematosus	0.000114	0.00208	CbGpPWpGaD
Clodronate—Urticaria—Methotrexate—systemic lupus erythematosus	0.000114	0.00115	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000113	0.00114	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	0.000112	0.00203	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000111	0.00201	CbGpPWpGaD
Clodronate—SLC25A6—Disease—JAK1—systemic lupus erythematosus	0.000111	0.00201	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—RXRA—systemic lupus erythematosus	0.000111	0.00201	CbGpPWpGaD
Clodronate—Vomiting—Prednisone—systemic lupus erythematosus	0.000109	0.0011	CcSEcCtD
Clodronate—SLC25A4—Disease—PRL—systemic lupus erythematosus	0.000108	0.00196	CbGpPWpGaD
Clodronate—Rash—Prednisone—systemic lupus erythematosus	0.000108	0.00109	CcSEcCtD
Clodronate—Dermatitis—Prednisone—systemic lupus erythematosus	0.000108	0.00109	CcSEcCtD
Clodronate—SLC25A6—Disease—CCR5—systemic lupus erythematosus	0.000105	0.00191	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000105	0.0019	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	0.000104	0.00188	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CD80—systemic lupus erythematosus	0.000103	0.00187	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CCL2—systemic lupus erythematosus	0.000102	0.00185	CbGpPWpGaD
Clodronate—Nausea—Prednisone—systemic lupus erythematosus	0.000102	0.00103	CcSEcCtD
Clodronate—Pruritus—Methotrexate—systemic lupus erythematosus	0.000101	0.00102	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.81e-05	0.00099	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	9.68e-05	0.00176	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	9.61e-05	0.00174	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	9.58e-05	0.00174	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	9.17e-05	0.00166	CbGpPWpGaD
Clodronate—Vomiting—Methotrexate—systemic lupus erythematosus	9.11e-05	0.00092	CcSEcCtD
Clodronate—Rash—Methotrexate—systemic lupus erythematosus	9.04e-05	0.000912	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—systemic lupus erythematosus	9.03e-05	0.000912	CcSEcCtD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	8.99e-05	0.00163	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	8.86e-05	0.00161	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	8.83e-05	0.0016	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TYK2—systemic lupus erythematosus	8.71e-05	0.00158	CbGpPWpGaD
Clodronate—SLC25A4—Disease—JAK1—systemic lupus erythematosus	8.66e-05	0.00157	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CD80—systemic lupus erythematosus	8.65e-05	0.00157	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—RXRA—systemic lupus erythematosus	8.63e-05	0.00157	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS3—systemic lupus erythematosus	8.55e-05	0.00155	CbGpPWpGaD
Clodronate—Nausea—Methotrexate—systemic lupus erythematosus	8.51e-05	0.000859	CcSEcCtD
Clodronate—SLC25A5—Metabolism—PPARG—systemic lupus erythematosus	8.33e-05	0.00151	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	8.33e-05	0.00151	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	8.22e-05	0.00149	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CCR5—systemic lupus erythematosus	8.21e-05	0.00149	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CD4—systemic lupus erythematosus	7.88e-05	0.00143	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—systemic lupus erythematosus	7.82e-05	0.00142	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	7.68e-05	0.00139	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	7.51e-05	0.00136	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ALB—systemic lupus erythematosus	7.49e-05	0.00136	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN1B—systemic lupus erythematosus	7.41e-05	0.00134	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	7.31e-05	0.00133	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TYK2—systemic lupus erythematosus	7.3e-05	0.00132	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	7.25e-05	0.00131	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS3—systemic lupus erythematosus	7.17e-05	0.0013	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NOS3—systemic lupus erythematosus	7.16e-05	0.0013	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	6.99e-05	0.00127	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARG—systemic lupus erythematosus	6.98e-05	0.00127	CbGpPWpGaD
Clodronate—SLC25A5—Disease—CDKN1A—systemic lupus erythematosus	6.84e-05	0.00124	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CD80—systemic lupus erythematosus	6.75e-05	0.00122	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CD4—systemic lupus erythematosus	6.6e-05	0.0012	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—systemic lupus erythematosus	6.56e-05	0.00119	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—systemic lupus erythematosus	6.55e-05	0.00119	CbGpPWpGaD
Clodronate—SLC25A5—Disease—EP300—systemic lupus erythematosus	6.51e-05	0.00118	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	6.34e-05	0.00115	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ALB—systemic lupus erythematosus	6.28e-05	0.00114	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN1B—systemic lupus erythematosus	6.21e-05	0.00113	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	6.21e-05	0.00113	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NOS3—systemic lupus erythematosus	6e-05	0.00109	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	5.88e-05	0.00107	CbGpPWpGaD
Clodronate—SLC25A6—Disease—CDKN1A—systemic lupus erythematosus	5.73e-05	0.00104	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	5.72e-05	0.00104	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TYK2—systemic lupus erythematosus	5.7e-05	0.00103	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—systemic lupus erythematosus	5.66e-05	0.00103	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—systemic lupus erythematosus	5.6e-05	0.00101	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—systemic lupus erythematosus	5.49e-05	0.000996	CbGpPWpGaD
Clodronate—SLC25A6—Disease—EP300—systemic lupus erythematosus	5.45e-05	0.000989	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—EP300—systemic lupus erythematosus	5.45e-05	0.000988	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—systemic lupus erythematosus	5.45e-05	0.000988	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CD4—systemic lupus erythematosus	5.16e-05	0.000935	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—systemic lupus erythematosus	5.12e-05	0.000928	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—systemic lupus erythematosus	4.9e-05	0.000889	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1B—systemic lupus erythematosus	4.85e-05	0.000879	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	4.84e-05	0.000878	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—systemic lupus erythematosus	4.74e-05	0.00086	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—systemic lupus erythematosus	4.69e-05	0.00085	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.61e-05	0.000837	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—EP300—systemic lupus erythematosus	4.57e-05	0.000828	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	4.52e-05	0.00082	CbGpPWpGaD
Clodronate—PTGS2—Disease—XRCC6—systemic lupus erythematosus	4.51e-05	0.000818	CbGpPWpGaD
Clodronate—SLC25A4—Disease—CDKN1A—systemic lupus erythematosus	4.47e-05	0.000811	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.32e-05	0.000783	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—systemic lupus erythematosus	4.29e-05	0.000777	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—systemic lupus erythematosus	4.26e-05	0.000773	CbGpPWpGaD
Clodronate—SLC25A4—Disease—EP300—systemic lupus erythematosus	4.26e-05	0.000772	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.98e-05	0.000722	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.83e-05	0.000695	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.79e-05	0.000687	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—systemic lupus erythematosus	3.7e-05	0.000671	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	3.65e-05	0.000662	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.59e-05	0.000651	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—systemic lupus erythematosus	3.57e-05	0.000648	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—EP300—systemic lupus erythematosus	3.56e-05	0.000647	CbGpPWpGaD
Clodronate—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	3.32e-05	0.000603	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.29e-05	0.000598	CbGpPWpGaD
Clodronate—PTGS2—Disease—CSK—systemic lupus erythematosus	3.24e-05	0.000588	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.08e-05	0.000558	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD247—systemic lupus erythematosus	3.05e-05	0.000552	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	3.04e-05	0.000552	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCF2—systemic lupus erythematosus	2.96e-05	0.000537	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—systemic lupus erythematosus	2.79e-05	0.000506	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.42e-05	0.000439	CbGpPWpGaD
Clodronate—PTGS2—Disease—JUNB—systemic lupus erythematosus	2.32e-05	0.000422	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.17e-05	0.000394	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRL—systemic lupus erythematosus	2.14e-05	0.000388	CbGpPWpGaD
Clodronate—PTGS2—Disease—JAK1—systemic lupus erythematosus	1.71e-05	0.000311	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	1.71e-05	0.000309	CbGpPWpGaD
Clodronate—PTGS2—Disease—CCR5—systemic lupus erythematosus	1.62e-05	0.000294	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.58e-05	0.000287	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD80—systemic lupus erythematosus	1.34e-05	0.000242	CbGpPWpGaD
Clodronate—PTGS2—Disease—TYK2—systemic lupus erythematosus	1.13e-05	0.000204	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.11e-05	0.000201	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.08e-05	0.000195	CbGpPWpGaD
Clodronate—PTGS2—Disease—CD4—systemic lupus erythematosus	1.02e-05	0.000185	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—systemic lupus erythematosus	9.69e-06	0.000176	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	9.58e-06	0.000174	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	9.27e-06	0.000168	CbGpPWpGaD
Clodronate—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	8.84e-06	0.00016	CbGpPWpGaD
Clodronate—PTGS2—Disease—EP300—systemic lupus erythematosus	8.42e-06	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—systemic lupus erythematosus	7.32e-06	0.000133	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—EP300—systemic lupus erythematosus	7.05e-06	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—systemic lupus erythematosus	5.51e-06	0.0001	CbGpPWpGaD
